(S) -2-benzyl-3- ( (3R, 4R) -4- (3 - carbamo ylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors

Details for Australian Patent Application No. 2010258925 (hide)

Owner Adolor Corporation

Inventors Dolle, Roland E.; Le Bourdonnec, Bertrand

Agent Watermark

Pub. Number AU-A-2010258925

PCT Pub. Number WO2010/144446

Priority 61/184,891 08.06.09 US; 12/795,095 07.06.10 US

Filing date 8 June 2010

Wipo publication date 16 December 2010

International Classifications

C07D 211/34 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/144446 Priority application(s): WO2010/144446

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258928-Electronic door lock for reduced power consumption

2010258919-Lubrication and exhaust system for a powered surgical instrument